Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.36% |
| 2 | Healthcare | 13.06% |
| 3 | Consumer Discretionary | 12.03% |
| 4 | Consumer Staples | 11.17% |
| 5 | Industrials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDR
851
DELISTED
McDermott International
MDR
| $9.1M | 0.02% |
331,296
-495,337
| -60% | -$11.6M |
|
|
DDC
852
DELISTED
Dominion Diamond Corporation
DDC
| $9.05M | 0.02% |
630,613
-30,631
| -5% | -$411K |
|
|
SGY
853
DELISTED
Stone Energy
SGY
| $9.02M | 0.02% |
4,590
-3,976
| -46% | -$7.61M |
|
854
Sun Life Financial
SLF
$44.4B
| $9.02M | 0.02% |
+255,200
| New | +$8.69M |
|
855
Enpro
NPO
$7.12B
| $9M | 0.02% |
156,100
-45,100
| -22% | -$2.59M |
|
|
IRF
856
DELISTED
INTL RECTIFIER CORP
IRF
| $9M | 0.02% |
345,100
+103,100
| +43% | +$2.51M |
|
857
Timken Company
TKR
$9.03B
| $8.96M | 0.02% |
227,432
-410,438
| -64% | -$16M |
|
858
SunCoke Energy
SXC
$801M
| $8.96M | 0.02% |
393,000
+220,900
| +128% | +$4.56M |
|
859
IQVIA
IQV
$39.8B
| $8.94M | 0.02% |
+192,900
| New | +$8.45M |
|
|
IGTE
860
DELISTED
IGATE CORPORATION
IGTE
| $8.9M | 0.02% |
221,749
+173,700
| +362% | +$5.79M |
|
861
Medifast
MED
$130M
| $8.89M | 0.02% |
340,400
-37,300
| -10% | -$956K |
|
|
AFFX
862
DELISTED
Affymetrix Inc
AFFX
| $8.85M | 0.02% |
1,032,500
+622,100
| +152% | +$4.77M |
|
|
PWRD
863
DELISTED
PERFECT WORLD CO LTD SPONSORED ADR REPSTG CL B (CAYMAN ISL)
PWRD
| $8.84M | 0.02% |
497,300
-1,004,500
| -67% | -$18.5M |
|
|
SWFT
864
DELISTED
Swift Transportation Company
SWFT
| $8.84M | 0.02% |
398,000
-471,700
| -54% | -$10.3M |
|
865
Toronto Dominion Bank
TD
$204B
| $8.84M | 0.02% |
187,580
-756,600
| -80% | -$34.4M |
|
|
EEP
866
DELISTED
Enbridge Energy Partners
EEP
| $8.81M | 0.02% |
294,900
+188,665
| +178% | +$5.63M |
|
867
Korn Ferry
KFY
$4.28B
| $8.81M | 0.02% |
337,215
+4,815
| +1% | +$114K |
|
|
LL
868
DELISTED
LL Flooring Holdings, Inc.
LL
| $8.79M | 0.02% |
85,400
-66,500
| -44% | -$7.07M |
|
|
SYT
869
DELISTED
Syngenta Ag
SYT
| $8.74M | 0.02% |
109,400
+49,000
| +81% | +$3.87M |
|
|
Y
870
DELISTED
Alleghany Corp
Y
| $8.71M | 0.02% |
21,788
+18,800
| +629% | +$7.5M |
|
|
AMWD
871
DELISTED
American Woodmark
AMWD
| $8.71M | 0.02% |
220,301
+57,401
| +35% | +$1.99M |
|
872
Louisiana-Pacific
LPX
$5.15B
| $8.69M | 0.02% |
469,600
-1,060,400
| -69% | -$18M |
|
873
White Mountains Insurance
WTM
$5.06B
| $8.68M | 0.02% |
14,400
+2,000
| +16% | +$1.18M |
|
|
CBST
874
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $8.67M | 0.02% |
125,920
-198,700
| -61% | -$12.9M |
|
875
Waters Corp
WAT
$40.9B
| $8.61M | 0.02% |
+86,100
| New | +$8.68M |
|
Similar funds
Jim Simons's Q4 2013 Portfolio in Review
As of Q4 2013, Jim Simons held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 983 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Pfizer worth $230M.
- Jim Simons's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Jim Simons added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Jim Simons's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Jim Simons fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Jim Simons's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Jim Simons opened 498 new positions and closed 464 in Q4 2013.
- Jim Simons's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.